CN101983717A - Traditional Chinese medicine for treating migraine - Google Patents

Traditional Chinese medicine for treating migraine Download PDF

Info

Publication number
CN101983717A
CN101983717A CN2010105037004A CN201010503700A CN101983717A CN 101983717 A CN101983717 A CN 101983717A CN 2010105037004 A CN2010105037004 A CN 2010105037004A CN 201010503700 A CN201010503700 A CN 201010503700A CN 101983717 A CN101983717 A CN 101983717A
Authority
CN
China
Prior art keywords
grams
herba
radix
chinese medicine
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105037004A
Other languages
Chinese (zh)
Inventor
刘树彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105037004A priority Critical patent/CN101983717A/en
Publication of CN101983717A publication Critical patent/CN101983717A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a traditional Chinese medicine for treating migraine. The component proportion of the medicament is as follows: Asarum Herb 10g, ephedra stem 10g, chuanxiong root 10g, prepared monkshood 10g, dahurian angelica root 10g, chrysanthemum 10g, mint 10g, notopterygium root 10g, windproof 10g, catnip 10g and dried ginger rhizome 10g. The accuracy of the ratio of the fixed dosages is plus or minus 10% of the above components. The traditional Chinese medicine has a quick, obvious and safe effect on treating migraine and is free of any toxic or side effect.

Description

A kind of Chinese medicine for the treatment of migraine
Technical field
The present invention relates to a kind of medicine of headache, a kind of specifically Chinese medicine for the treatment of migraine.
Background technology
Migraine is a kind of pulsatile headache of showing effect repeatedly, belongs to " rich and influential family " in numerous headache types.Tendencys such as flash of light, blurred vision, numb limbs and tense tendons are often arranged before the outbreak, simultaneously can be with neural, moral function obstacle.It is a kind of disease that can progressively worsen, and frequency of disease development is more and more higher usually, yet at present most medicine all contains hormone, and toxic and side effects is bigger, takes to be absolutely unsafe.
Summary of the invention
In order to solve the unfavorable problem of some curative effects at the medicine existence of treatment migraine, the invention provides a kind of Chinese medicine for the treatment of migraine, the Chinese medicine instant effect of this kind treatment migraine, drug effect is remarkable, safe and effective, and is without any side effects.
Concrete proportioning of the present invention is: Herba Asari 10 gram, Herba Ephedrae 10 grams, Rhizoma Chuanxiong 10 grams, Radix Aconiti Lateralis Preparata 10 grams, the Radix Angelicae Dahuricae 10 grams, Flos Chrysanthemi 10 grams, Herba Menthae 10 grams, Rhizoma Et Radix Notopterygii 10 grams, Radix Saposhnikoviae 10 grams, Herba Schizonepetae 10 grams, Rhizoma Zingiberis 10 grams, the degree of accuracy of the dose of this Chinese medicine be each medicine ± 10%.
Pharmacology of the present invention is: Herba Asari: dispel the wind, and cold expelling, row water is had one's ideas straightened out, and controls air-cooled headache, nasal sinusitis, toothache, phlegm retention cough with dyspnea, rheumatic arthralgia; Herba Ephedrae: diaphoresis cold expelling, depressed lung-energy dispersing, inducing diuresis to remove edema; Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping; Radix Aconiti Lateralis Preparata: it is supporing yang to mend fire, by wind-cold damp pathogen; The Radix Angelicae Dahuricae: expelling wind and cold, understand things pain-stopping, detumescence and apocenosis, dampness leukorrhagia stopping; Flos Chrysanthemi: the wind heat clearing away of loosing, suppressing the hyperactive liver makes eye bright; Herba Menthae: sweating and heat resolving medicine; Rhizoma Et Radix Notopterygii: diaphoretic medicine; Medicine for rheumatism; Radix Saposhnikoviae: expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion; Herba Schizonepetae: town's expectorant, timid wind, removing heat from blood; Rhizoma Zingiberis: warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, the dampness expectorant.
Preparing process of the present invention: Herba Asari, Herba Ephedrae, Rhizoma Chuanxiong, Radix Aconiti Lateralis Preparata, the Radix Angelicae Dahuricae, Flos Chrysanthemi, Herba Menthae, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Herba Schizonepetae, Rhizoma Zingiberis are mixed together into sieve, dash with the clear water sieve, pull oven dry out, grind to form fine powder, machine is made ball.
Administrated method of the present invention is: every day three times, and a 4-5 gram, ten days is a course of treatment.
The invention has the beneficial effects as follows: the Chinese medicine instant effect of this kind treatment migraine, drug effect is remarkable, safe and effective, and is without any side effects.
Specific embodiment
Through over 4 years, the clinical practice to 100 examples are treated the patient of migraine has obtained curative effect preferably, and total effective rate reaches 95%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select projects such as medical history, the state of an illness, age, sex and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to the clinical manifestation and the pathological characters branch of treatment migraine, sex, age are not limit, stop using before the treatment other various medicines and therapeutic modality.
4. preparing process: Herba Asari, Herba Ephedrae, Rhizoma Chuanxiong, Radix Aconiti Lateralis Preparata, the Radix Angelicae Dahuricae, Flos Chrysanthemi, Herba Menthae, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Herba Schizonepetae, Rhizoma Zingiberis are mixed together into sieve, dash with the clear water sieve, pull oven dry out, grind to form fine powder, machine is made ball.
5. administrated method: every day three times, a 4-5 gram, ten days is a course of treatment.
6. efficacy evaluation
1. recovery from illness: transference cure, thoroughly recovery from illness.
2. remarkable: curing does not afterwards have recurrence more than 1 year.
3. effective: various migraine patients' complications shape significantly reduces.
4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. sex: according to going into the group standard, we treat migraine patient 100 examples altogether, male's 60 examples (60%) wherein, women's 40 examples (40%).
2. the course of disease: 6 months~1 year is 15 examples, and 2 years~3 years is 50 examples, is 35 examples more than 3 years.
3. age group: 20~30 years old 35 example, 31~40 years old 5 example, 41~50 years old 20 example, 51~60 years old 30 example, 10 examples more than 60 years old.
4. prepare the dose scheme for first kind: Herba Asari 11 restrains, Herba Ephedrae 11 restrains, Rhizoma Chuanxiong 11 restrains, Radix Aconiti Lateralis Preparata 11 restrains, the Radix Angelicae Dahuricae 11 restrains, Flos Chrysanthemi 11 restrains, Herba Menthae 11 restrains, Rhizoma Et Radix Notopterygii 11 restrains, Radix Saposhnikoviae 11 restrains, Herba Schizonepetae 11 restrains, Rhizoma Zingiberis 11 restrains.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 50 examples 40 7 2 1
Moderate patient's 35 examples 30 2 2 1
Severe patient 15 examples 12 1 1 1
The scheme of second kind of preparation dose: Herba Asari 10 grams, Herba Ephedrae 10 grams, Rhizoma Chuanxiong 10 grams, Radix Aconiti Lateralis Preparata 10 grams, the Radix Angelicae Dahuricae 10 grams, Flos Chrysanthemi 10 grams, Herba Menthae 10 grams, Rhizoma Et Radix Notopterygii 10 grams, Radix Saposhnikoviae 10 grams, Herba Schizonepetae 10 grams, Rhizoma Zingiberis 10 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 45 examples 35 8 1 1
Moderate patient's 40 examples 35 3 1 1
Severe patient 15 examples 10 3 1 1
The scheme of the third preparation dose: Herba Asari 9 grams, Herba Ephedrae 9 grams, Rhizoma Chuanxiong 9 grams, Radix Aconiti Lateralis Preparata 9 grams, the Radix Angelicae Dahuricae 9 grams, Flos Chrysanthemi 9 grams, Herba Menthae 9 grams, Rhizoma Et Radix Notopterygii 9 grams, Radix Saposhnikoviae 9 grams, Herba Schizonepetae 9 grams, Rhizoma Zingiberis 9 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 50 examples 40 8 1 1
Moderate patient's 40 examples 35 3 1 1
Severe patient 10 examples 7 1 1 1
By Chinese medicine Drug therapy migraine of the present invention, received satisfied curative effect.The symptom of this disease is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.
Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, especially Western medicine is for oral administration, and side effect is bigger, and human body is developed immunity to drugs and causes very big toxic and side effects.In the process of taking Chinese medicine medicine of the present invention, must not take Western medicine and use injection, or other treats this sick medicine.Migraine symptoms such as the Chinese medicine of this kind treatment migraine is panted, tachypnea, uncomfortable in chest or cough, drug effect is remarkable, safe and effective, and is without any side effects, and cure rate reaches 95%.

Claims (2)

1. Chinese medicine for the treatment of migraine, it is characterized in that: concrete proportioning of the present invention is Herba Asari 10 gram, Herba Ephedrae 10 grams, Rhizoma Chuanxiong 10 grams, Radix Aconiti Lateralis Preparata 10 grams, the Radix Angelicae Dahuricae 10 grams, Flos Chrysanthemi 10 grams, Herba Menthae 10 grams, Rhizoma Et Radix Notopterygii 10 grams, Radix Saposhnikoviae 10 grams, Herba Schizonepetae 10 grams, Rhizoma Zingiberis 10 grams, the degree of accuracy of the dose of this Chinese medicine be each medicine ± 10%.
2. a kind of Chinese medicine for the treatment of migraine according to claim 1, it is characterized in that: Herba Asari, Herba Ephedrae, Rhizoma Chuanxiong, Radix Aconiti Lateralis Preparata, the Radix Angelicae Dahuricae, Flos Chrysanthemi, Herba Menthae, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Herba Schizonepetae, Rhizoma Zingiberis are mixed together into sieve, dash, pull oven dry out with the clear water sieve, grind to form fine powder, machine is made ball.
CN2010105037004A 2010-10-08 2010-10-08 Traditional Chinese medicine for treating migraine Pending CN101983717A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105037004A CN101983717A (en) 2010-10-08 2010-10-08 Traditional Chinese medicine for treating migraine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105037004A CN101983717A (en) 2010-10-08 2010-10-08 Traditional Chinese medicine for treating migraine

Publications (1)

Publication Number Publication Date
CN101983717A true CN101983717A (en) 2011-03-09

Family

ID=43640882

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105037004A Pending CN101983717A (en) 2010-10-08 2010-10-08 Traditional Chinese medicine for treating migraine

Country Status (1)

Country Link
CN (1) CN101983717A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102670708A (en) * 2012-06-06 2012-09-19 黄芸 Chinese medicinal oral liquid for treating migraine and preparation method thereof
CN102813886A (en) * 2012-08-20 2012-12-12 魏杰梅 Traditional Chinese medicine preparation for treating migraine
CN104435179A (en) * 2013-09-23 2015-03-25 刘吉 Medicine for treating headache
CN105796793A (en) * 2016-05-03 2016-07-27 穆静丽 Traditional Chinese medicine composition capable of treating migraine in neurology department
CN106729539A (en) * 2016-12-22 2017-05-31 广州肇基生物科技有限公司 A kind of Chinese medicine compound prescription tea and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102670708A (en) * 2012-06-06 2012-09-19 黄芸 Chinese medicinal oral liquid for treating migraine and preparation method thereof
CN102813886A (en) * 2012-08-20 2012-12-12 魏杰梅 Traditional Chinese medicine preparation for treating migraine
CN102813886B (en) * 2012-08-20 2014-05-07 魏杰梅 Traditional Chinese medicine preparation for treating migraine
CN104435179A (en) * 2013-09-23 2015-03-25 刘吉 Medicine for treating headache
CN105796793A (en) * 2016-05-03 2016-07-27 穆静丽 Traditional Chinese medicine composition capable of treating migraine in neurology department
CN106729539A (en) * 2016-12-22 2017-05-31 广州肇基生物科技有限公司 A kind of Chinese medicine compound prescription tea and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103690909A (en) Externally-applied traditional Chinese medicine for treating rheumatic arthritis
CN101983717A (en) Traditional Chinese medicine for treating migraine
CN104415317A (en) Plaster
CN102078462A (en) Asthma relieving medicament
CN103656025B (en) A kind of medical liquor for treating injury
CN104383445A (en) Traumatic injury analgesic
CN102145101A (en) Novel traditional Chinese medicine for treating rheumatic lumbocrural pains
CN103845429A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101983644A (en) Medicament for treating sequelae of apoplexy
CN103784804A (en) Pharmaceutical composition for treating benign prostatic hyperplasia
CN102078472A (en) Medicament for treating verruca wart
CN101983652A (en) Traditional Chinese medicine for treating scapulohumeral periarthritis
CN101983672A (en) Medicament for treating cramp
CN101983682A (en) Medicament for treating female climacteric metancholia
CN102078432A (en) Medicament for treating skin itch
CN101983650A (en) Medicament for treating dermatitis aestivale
CN103768368B (en) A kind of Chinese medicine composition treating acute epididymitis
CN101979036A (en) Medicinal liquor for treating rheumatic arthritis
CN101961455A (en) Traditional Chinese medicine for treating chronic colitis disease
CN101791372A (en) Chinese medicine for treating radiation pharyngitis
CN104997972A (en) Traditional Chinese medicine preparation for treating radiodermatitis
CN101983719A (en) Novel medicament for treating lung cancer
CN101983676A (en) Medicament for treating gynecological blood stasis and qi stagnation
CN102716435A (en) Traditional Chinese medicine feet-soaking preparation for treating diabetic foot
CN101983681A (en) Medicament for treating abnormal leucorrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110309